But the other meta-analysis reported that the hOGG1 polymorphism may contribute to the susceptibility of digestive cancers, breast cancer, colorectal cancer, esophageal squamous cell carcinoma, hepatocellular carcinoma, head and neck cancer, and prostate cancer. The gene discussed is OGG1; the disease is breast cancer.